KCNMA1 and fragile X syndrome: Taken together, these findings suggest that FMRP acts via BK channels in the hippocampus and other brain regions, and that the functional alteration of these channels may result in an abnormally high neurotransmitter release contributing to the synaptic alteration in FXS.